Health Canada issues revised guidance on interpretation of a significant change to a device
This article was originally published in RAJ Devices
Executive Summary
Health Canada has issued revised guidance on the interpretation of a significant change to a class III or IV (medium-high and highest-risk) medical device that would require a manufacture to apply for an amended product licence1,2.